Nothing Special   »   [go: up one dir, main page]

Kojima et al., 1992 - Google Patents

Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.

Kojima et al., 1992

View PDF @Full View
Document ID
4989791340353446893
Author
Kojima T
Leone C
Marchildon G
Marcum J
Rosenberg R
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

We have isolated heparan sulfate proteoglycans (HSPGs) from cloned rat microvascular endothelial cells using a combination of ion-exchange chromatography, affinity fractionation with antithrombin III (AT III), and gel filtration in denaturing solvents. The anticoagulantly …
Continue reading at www.jbc.org (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Similar Documents

Publication Publication Date Title
Kojima et al. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.
Marcum et al. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.
Bourin et al. Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan.
Rosenberg et al. Correlation between structure and function of heparin
Rosenberg et al. Structure-function relationships of heparin species
Fritze et al. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells.
Thunberg et al. Further characterization of the antithrombin-binding sequence in heparin
Lyon et al. Liver heparan sulfate structure. A novel molecular design
Rosenberg Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism
Bach et al. The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase
Griffin et al. Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin
Oldberg et al. Characterization of platelet endoglycosidase degrading heparin-like polysaccharides
Hook et al. Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin
Pejler et al. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides.
Riesenfeld et al. The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups.
Winterbourne et al. Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation.
Wright et al. Structural determinants of heparin's growth inhibitory activity: interdependence of oligosaccharide size and charge
IE51166B1 (en) Oligosaccharides and oligosaccharide fractions having biological properties,processes for obtaining them and pharmaceutical compositions containing them
Uhlin-Hansen et al. Differential effect of brefeldin A on the biosynthesis of heparan sulfate and chondroitin/dermatan sulfate proteoglycans in rat ovarian granulosa cells in culture
Damm et al. Separation of natural and synthetic heparin fragments by high-performance capillary electrophoresis
Midura et al. Analysis of the proteoglycans synthesized by corneal explants from embryonic chicken: II. Structural characterization of the keratan sulfate and dermatan sulfate proteoglycans from corneal stroma
Fransson et al. Proteoheparan sulfate from human skin fibroblasts. Evidence for self-interaction via the heparan sulfate side chains.
Ellis et al. The relative molecular mass dependence of the anti-factor Xa properties of heparin
Bame et al. Coupling of N-deacetylation and N-sulfation in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase
Yaoita et al. Isolation and characterization of proteoglycans synthesized by cultured mesangial cells.